Molecular international prognostic scoring system for myelodysplastic syndromes
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F22%3A00013425" target="_blank" >RIV/00023736:_____/22:00013425 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1056/EVIDoa2200008" target="_blank" >https://doi.org/10.1056/EVIDoa2200008</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1056/EVIDoa2200008" target="_blank" >10.1056/EVIDoa2200008</a>
Alternative languages
Result language
angličtina
Original language name
Molecular international prognostic scoring system for myelodysplastic syndromes
Original language description
Risk stratification and therapeutic decision-making for myelodysplastic syndromes (MDS) are based on the International Prognostic Scoring System–Revised (IPSS-R), which considers hematologic parameters and cytogenetic abnormalities. Somatic gene mutations are not yet used in the risk stratification of patients with MDS.
Czech name
—
Czech description
—
Classification
Type
J<sub>ost</sub> - Miscellaneous article in a specialist periodical
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
NEJM evidence
ISSN
2766-5526
e-ISSN
—
Volume of the periodical
1
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
14
Pages from-to
"nestr."
UT code for WoS article
—
EID of the result in the Scopus database
—